SOURCE: Medivation

Medivation

December 17, 2014 16:10 ET

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA--(Marketwired - Dec 17, 2014) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • David Hung, M.D., president and chief executive officer will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 4:30pm PT at the Westin St. Francis Hotel, San Francisco, CA

Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm. A replay of the webcast will be available on the Company's website for 30 days following the live event.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically-innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, visit www.medivation.com.

Contact Information

  • Contacts:
    Anne Bowdidge
    Sr. Director, Investor Relations
    (650) 218-6900